2025-05-02 18:56:56
Latest Post
LKP Securities Ltd consolidated Q4FY25 profit up QoQ at Rs. 2.69 crore
Krystal Integrated Services Ltd Q4 FY2025 consolidated net profit up at Rs. 11.84 crores
ELANTAS Beck India Ltd Q1 CY2025 PAT higher QoQ at Rs. 32.86 crores
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Stock Report
Alembic Pharmaceuticals Ltd Q1FY21 consolidated net profit higher at Rs. 295.76 crore
Posted On : 2020-07-22 14:36:26( TIMEZONE : IST )
ALEMBIC PHARMACEUTICALS LTD. has reported financial results for the period ended June 30, 2020.
Financial Results (Q1 FY 2020-21) - QoQ Comparison
The company has reported total income of Rs.1341.64 crores during the period ended June 30, 2020 as compared to Rs.1207.72 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.295.76 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.222.08 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.15.99 for the period ended June 30, 2020 as compared to Rs.11.92 for the period ended March 31, 2020.
| Financials | Q1 FY2020-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 1341.64 crs | ₹ 1207.72 crs |  11.09% |
| Net Profit | ₹ 295.76 crs | ₹ 222.08 crs | 33.18% |
| EPS | ₹ 15.99 | ₹ 11.92 | 34.14% |
Financial Results (Q1 FY 2020-21) - YoY Comparison
The company has reported total income of Rs.1341.64 crores during the period ended June 30, 2020 as compared to Rs.952.20 crores during the period ended June 30, 2019.
The company has posted net profit / (loss) of Rs.295.76 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.121.43 crores for the period ended June 30, 2019.
The company has reported EPS of Rs.15.99 for the period ended June 30, 2020 as compared to Rs.6.56 for the period ended June 30, 2019.
| Financials | Q1 FY2020-21 | Q1 FY2019-20 | % Change |
| Total Income | ₹ 1341.64 crs | ₹ 952.20 crs | 40.9% |
| Net Profit | ₹ 295.76 crs | ₹ 121.43 crs | 143.56% |
| EPS | ₹ 15.99 | ₹ 6.56 | 143.75% |
Mr. Pranav Amin, Managing Director, Alembic Pharmaceuticals Limited said "It was an excellent quarter for the company backed by growth in all the international markets. Despite exceptionally, challenging circumstances, the operating teams ensured profitability and growth."
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.994.7 as compared to the previous close of Rs. 1014.05. The total number of shares traded during the day was 34748 in over 2846 trades.
The stock hit an intraday high of Rs. 1027 and intraday low of 985.6. The net turnover during the day was Rs. 34657501.
